OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Medical Screening is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Introduction of one-view tomosynthesis in population-based mammography screening: Impact on detection rate, interval cancer rate and false-positive rate	56
Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey	35
Lymphoproliferative disease detected by breast cancer screening	25
Couple screening for recessively inherited disorders	24
NHS announces a pilot of a blood test for early detection of many cancers	22
Cell-free DNA-based prenatal screening via rolling circle amplification: Identifying and resolving analytic issues	22
Interval cancer audit and disclosure in breast screening programmes: An international survey	20
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review	18
Comparison of cytology and human papillomavirus-based primary testing in cervical screening programs in the Nordic countries	17
Newborn screening for biliary atresia using direct bilirubin: An implementation science study	13
Detection and significance of small and low proliferation breast cancer	11
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening	11
Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England	10
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening	10
Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis	10
Identifying optimum implementation for human papillomavirus self-sampling in underserved communities: A systematic review	9
HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial	9
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographers	9
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis	9
The impact of age at initial HPV vaccination on cervical cancer screening participation in a nationally representative cohort of women in the United States	9
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study	8
Estimating stage-specific sensitivity for cancer screening tests	8
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States	8
Combining genetic and non-genetic risk factors to predict disease, and reporting the screening performance of risk models	8
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada	7

Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic	7
When primary prevention replaces screening	7
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost–utility analysis	6
Optimising recruitment to a lung cancer screening trial: A comparison of general practitioner and community-based recruitment	6
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020	5
Colonoscopy may be weak link in organised colorectal cancer screening programme with faecal immunochemical test	5
Artificial intelligence for triaging of breast cancer screening mammograms and workload reduction: A meta-analysis of a deep learning software	5
Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women	5
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing	5
Impact of cumulative experience on the quality of screening colonoscopy: A 13-year observational study	4
Google search volume trends for cancer screening terms during the COVID-19 pandemic	4
Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes	4
Are screening practice ethics committees needed?	4
Risk stratification in medical screening	4
Age at breast cancer screening in women with intellectual disability	4
Long-term colorectal cancer incidence in a post-endoscopic screening cohort, accounting for surveillance, by baseline polyp group, anatomic subsite, and sex	3
Trends in colorectal cancer screening in the United States, 2012 to 2020	3
The randomized trial of mammography screening that was not—A cautionary tale	3
Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland	3
Simulated arbitration of discordance between radiologists and artificial intelligence interpretation of breast cancer screening mammograms	3
Wide variability in colorectal cancer screening uptake by general practitioner: Cross-sectional study	3
Breast cancer mortality after eight years of an improved screening program using digital breast tomosynthesis	3
The polypill in the primary prevention of heart attacks and strokes: Overcoming barriers to implementation	2
Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study	2
HPV self-sampling in organized cervical cancer screening program: A randomized pilot study in Estonia in 2021	2
Timely adherence to follow-up after high-risk lung cancer screenings	2
Hybrid capture 2 and cobas® 4800: Comparison of performance of two clinically validated tests for human papillomavirus primary screening of cervical cancer	2
Infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis and acute recurrent pancreatitis: what definition?	2
COVID-19 disruption to cervical cancer screening in England	2
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes	2
Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection de	2
Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test	2
Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review	2
Impact of cancer screening on metastasis: A prostate cancer case study	2
Predicting perinatal outcomes with an obstructive sleep apnea screening tool	2
The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis	2
Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study	1
Systematic review and meta-analysis of colon capsule endoscopy accuracy for colorectal cancer screening. An alternative during the Covid-19 pandemic?	1
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study	1
The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area	1
The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort	1
One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain)	1
Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test	1
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality	1
Carrier rate of thalassemia among 25,910 high school students in Shaoguan area, China	1
Colorectal cancer screening with faecal immunochemical test: Patterns of participation	1
The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy	1
Outcome of premarital genetic counseling for couples at risk of hemoglobinopathies in Kingdom of Bahrain	1
Examining breast cancer screening recommendations in Canada: The projected resource impact of screening among women aged 40–49	1
Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue	1

Deaths averted: An unbiased alternative to rate ratios for measuring the performance of cancer screening programs	1
Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement	1
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India	1
The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia	1
Breast cancer mortality during the COVID-19 pandemic	1
Public health perspective on prostate-specific antigen screening: Implications of overdiagnosis and differences in health insurance systems across countries	1
Recovery of the breast screening programme following pandemic-related delays: Should we focus on round length or uptake?	1
Anxiety and disease awareness in individuals with heredity for abdominal aortic aneurysm	1
The recalibration and redevelopment of a model to calculate patients’ probability of completing a colonoscopy following an abnormal fecal test	1
Applying the healthcare failure mode and effects analysis approach to improve the quality of an organised colorectal cancer screening programme	1
Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test	1
The impact of cumulative colorectal cancer screening delays: A simulation study	1
Prevalence of colorectal cancer and breast cancer screening according to history of diabetes in 2010–2019	1
Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs	1
Postscript to ‘Folic acid and neural tube defects: Discovery, debate and the need for policy change’	1
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis	1
Thanks to reviewers	1
Primary care outreach and decision counseling for lung cancer screening	1
How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes	1
Percentage mammographic density or absolute breast density for risk stratification in breast screening: Possible implications for socioeconomic health disparity	1
Testing outside of the National Bowel and Breast Cancer Screening Programs in Queensland, Australia	1